Log in

Relevant bibliographies by topics / Pediatric pharmacology

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Pediatric pharmacology'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pediatric pharmacology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pediatric pharmacology"

1

Peiré García, Mª Asunción. "Pediatric pharmacology." ANALES RANM 136, no. 02 (September 25, 2019): 218–21. http://dx.doi.org/10.32440/ar.2019.136.02.rev17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kaguelidou, Florentia, Behrouz Kassai Koupai, and Genevieve Durrieu. "Pediatric pharmacology." Therapies 73, no. 2 (April 2018): 111–12. http://dx.doi.org/10.1016/j.therap.2018.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Poon, Cathy Y., and Rosalie Sagraves. "Pediatric pharmacology." Journal of Pediatric Health Care 7, no. 3 (May 1993): 127–33. http://dx.doi.org/10.1016/0891-5245(93)90093-w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mukherjee, B. P. "Pediatric pharmacology." Indian Journal of Otolaryngology and Head and Neck Surgery 46, no. 4 (October 1994): 233. http://dx.doi.org/10.1007/bf03048593.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

KIMURA, TOSHIMI. "Clinical Pharmacology of Pediatric Patients: Pharmacology of Antibiotics in Pediatrics." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 35, no. 6 (2004): 280–84. http://dx.doi.org/10.3999/jscpt.35.6_280.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sepúlveda, Pablo O., Valeria Epulef, and Gustavo Campos. "Why do We Use the Concepts of Adult Anesthesia Pharmacology in Developing Brains? Will It Have an Impact on Outcomes? Challenges in Neuromonitoring and Pharmacology in Pediatric Anesthesia." Journal of Clinical Medicine 10, no. 10 (May 18, 2021): 2175. http://dx.doi.org/10.3390/jcm10102175.

Full text

Abstract:

Background: Pediatric sedation and anesthesia techniques have plenty of difficulties and challenges. Data on the pharmacologic, electroencephalographic, and neurologic response to anesthesia at different brain development times are only partially known. New data in neuroscience, pharmacology, and intraoperative neuromonitoring will impact changing concepts and clinical practice. In this article, we develop a conversation to guide the debate and search for a view more attuned to the updated knowledge in neurodevelopment, electroencephalography, and clinical pharmacology for the anesthesiologic practice in the pediatric population.

APA, Harvard, Vancouver, ISO, and other styles

7

Woo, Teri Moser. "Pediatric Pharmacology Update." Advances in Family Practice Nursing 3 (May 2021): 169–81. http://dx.doi.org/10.1016/j.yfpn.2021.02.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Park, Min Soo. "Pediatric Clinical Pharmacology." Journal of Korean Society for Clinical Pharmacology and Therapeutics 4, no. 2 (1996): 239. http://dx.doi.org/10.12793/jkscpt.1996.4.2.239.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zaritsky, Arno. "Pediatric resuscitation pharmacology." Annals of Emergency Medicine 22, no. 2 (February 1993): 445–55. http://dx.doi.org/10.1016/s0196-0644(05)80477-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pelayo, Rafael, and Kin Yuen. "Pediatric Sleep Pharmacology." Child and Adolescent Psychiatric Clinics of North America 21, no. 4 (October 2012): 861–83. http://dx.doi.org/10.1016/j.chc.2012.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Pediatric pharmacology"

1

Sun, Pei-Chen Angela. "Paediatric pharmacovigilance : utility of routinely acquired healthcare data." Thesis, University of Aberdeen, 2014. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=225729.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Belon, Howard Porter 1957. "TEACHERS' KNOWLEDGE AND ATTITUDES TOWARD CHILDREN'S MEDICATIONS." Thesis, The University of Arizona, 1986. http://hdl.handle.net/10150/276341.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Tang, Lisa Eng. "Age-associated hepatic drug transporter expression and its implications for pediatric pharmacotherapy." View the abstract Download the full-text PDF version, 2007. http://etd.utmem.edu/ABSTRACTS/2007-027-Tang-Index.html.

Full text

Abstract:

Thesis (Ph.D. )--University of Tennessee Health Science Center, 2007.
Title from title page screen (viewed on June 19, 2008). Research advisor: Bernd Meibohm, Ph.D. Document formatted into pages (xiv, 100 p. : ill.). Vita. Abstract. Includes bibliographical references (p. 96-100).

APA, Harvard, Vancouver, ISO, and other styles

4

Soderstrom, David. "Fuzzy logic modeling and intelligent sliding mode control techniques for the individualization of theophylline therapy to pediatric patients." Thesis, Georgia Institute of Technology, 1992. http://hdl.handle.net/1853/19097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rohan, Jennifer M. "The Relationship of 6-Mercaptopurine Medication Adherence to Clinical Outcomes in Pediatric Cancer." University of Cincinnati / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1416570460.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Easton-Carter, Kylie 1973. "The consequences of drug related problems in paediatrics." Monash University, Dept. of Pharmacy Practice, 2001. http://arrow.monash.edu.au/hdl/1959.1/8988.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mack, Elizabeth H. "Propofol as a bridge to extubation in the pediatric intensive care unit." University of Cincinnati / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1243354898.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lilley, Christine Megan. "Psychological predictors of children's pain and parents' medication practices following pediatric day surgery." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2000. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ56577.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kunac, Desirée L., and n/a. "Adverse drug events and medication errors in a paediatric inpatient population." University of Otago. Dunedin School of Medicine, 2005. http://adt.otago.ac.nz./public/adt-NZDU20060707.161220.

Full text

Abstract:

Background. Medication-related patient injuries (adverse drug events, ADEs) are an important problem in all hospitalised populations; however, the potential for injury is reported to be greater in children than adults. Many ADEs are due to error and therefore could be prevented. Data regarding the risk factors (or predictors) for these events in paediatric inpatients is limited. It was hypothesised that "identification of risk factors for ADEs and medication errors in the paediatric inpatient setting will inform likely prevention strategies". Aims. To determine the frequency, nature and risk factors for ADEs and potential ADEs occurring in a paediatric inpatient population; to assess the vulnerable processes in the neonatal intensive care unit (NICU) medication use process; and to provide recommendations for the targeting of likely prevention strategies. Setting. A general paediatric ward (PW), postnatal ward (PNW) and NICU of a University- affiliated urban general hospital. Design. There were two study components: the medEVENT study which involved identification of actual ADEs and potential ADEs over a twelve week period, through prospective review of medical records, medication charts and administration records along with voluntary and solicited staff report and parent interview; and the FMEA study which used a proactive risk assessment technique, Failure Mode and Effect Analysis (FMEA), to rank all potential failures in the NICU medication use process according to risk. Results. In the MedEVENT study 3160 prescription episodes were reviewed (which represented 520 admissions, 3037 patient-days) and revealed a total of 67 ADEs and 77 potential ADEs. The greatest number of events occurred in NICU with very few events in the PNW. However, paediatric surgical admissions experienced the highest rate of ADEs per 1000 patient-days (80) as compared to medical (65) then NICU admissions (19). Over half of the ADEs were deemed preventable, 38 (57%), with the �more serious� ADEs more likely to be preventable than �not serious� ADEs. The impact on hospital resources was considerable with the cost attributed to extra bed days due to ADEs to be $NZD 50,000. Dosing errors were the most common type of error, particularly when prescribing and administering medications. Antibacterial and narcotic analgesics were commonly implicated, as was the intravenous route of administration. Few events were related to unlicensed use of medications. For ADEs, the major risk factors when analysed by admission, were greater medication exposure and increasing age; by prescription, were increasing age, oral route and narcotics and antibacterial agents; for paediatric ward admission, were increasing age and increased length of stay; and for NICU admission, no major risk factors emerged. For potential ADEs, the major risk factors when analysed by admission were greater medication exposure; by prescription, were junior prescriber, intravenous route, narcotics and antibacterials; for paediatric ward admission, were junior prescriber and narcotics; and for NICU admission were antibacterials, electrolytes and umbilical venous catheter administration. Neither ADEs nor potential ADEs were associated with unlicensed use of medicines or high alert status drugs. The FMEA study identified 72 potential failures in the NICU medication use process with 193 associated causes and effects. Multiple failures were possible in the process of �prescribing medication� and in the process of �preparation of medication for administration�. The highest ranking issues were found to occur at the administration stage. Common potential failures related to errors in the dose, timing of administration, infusion pump settings and route of administration. Conclusions. Analysis of the risk factors of ADEs and potential ADEs found that the most vulnerable processes were when prescribing and when preparing a medicine for administration; especially when involving narcotic and antibacterial agents and for children with greater medication exposure Strategies that selectively target these high risk areas are therefore likely to have the greatest impact on preventing drug-related injuries in hospitalised children.

APA, Harvard, Vancouver, ISO, and other styles

10

Allen, Paul H. "Pharmacological Management of Acute Dental Pain in Children; Attitudes and Beliefs of Caregivers." The Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=osu1242045989.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Pediatric pharmacology"

1

Seyberth, Hannsjörg W., Anders Rane, and Matthias Schwab, eds. Pediatric Clinical Pharmacology. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-20195-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Schwab, M., Hannsjörg W. Seyberth, and Anders Rane. Pediatric clinical pharmacology. New York: Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Iftekhar, Mahmood. Pediatric pharmacology and pharmacokinetics. Rockville, Md: Pine House Pub., 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

C, Radde Ingeborg, and MacLeod Stuart M, eds. Pediatric pharmacology and therapeutics. 2nd ed. St. Louis: Mosby, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

C, Radde Ingeborg, ed. Textbook of pediatric clinical pharmacology. Littleton, Mass: PSG Pub. Co., 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

1923-, Yaffe Sumner J., and Aranda Jacob V, eds. Pediatric pharmacology: Therapeutic principles in practice. 2nd ed. Philadelphia: Saunders, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lockhart, Jean. Drug development and the pediatric population: Report of a workshop. Washington, D.C: National Academy Press, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Poplack, D. G., L. Massimo, and P. Cornaglia-Ferraris, eds. The Role of Pharmacology in Pediatric Oncology. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-4267-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

G, Poplack David, Massimo Luisa, and Cornaglia Ferraris Paolo, eds. The Role of pharmacology in pediatric oncology. Dordrecht: Nijhoff, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Association, British Medical. BNF for children 2015-2016. London: BMJ Group, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Pediatric pharmacology"

1

Mazoit, Jean X. "Pharmacology." In Gregory's Pediatric Anesthesia, 168–204. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444345186.ch9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kavanagh, Robert P., Lindsay C. Trout, and Gretchen L. Brummel. "Pharmacology." In Pediatric Critical Care, 123–52. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-53363-2_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Smith, Janis Bloedel. "Cardiovascular Pharmacology." In Pediatric Cardiology, 746–57. New York, NY: Springer New York, 1986. http://dx.doi.org/10.1007/978-1-4613-8598-1_204.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Brummel, Gretchen L., and Steven E. Lucking. "Pharmacology." In Pediatric Critical Care Study Guide, 334–51. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-923-9_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lozano, Maria José Santiago, Jesús López-Herce Cid, and Andrés Alcaraz Romero. "Kidney Pharmacology." In Pediatric Critical Care Medicine, 233–40. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6416-6_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lerman, Jerrold, Charles J. Coté, and David J. Steward. "Clinical Pharmacology." In Manual of Pediatric Anesthesia, 39–75. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30684-1_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Greco, Christine D., and Navil F. Sethna. "Neonatal and Pediatric Pharmacology." In Opioid Therapy in Infants, Children, and Adolescents, 79–94. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-36287-4_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hirschfeld, Steven, and Agnes Saint-Raymond. "Pediatric Regulatory Initiatives." In Pediatric Clinical Pharmacology, 245–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-20195-0_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sommerauer, John F., Andrea R. Chamberlain, and Trina Devadhar Hemmelgarn. "Pharmacology of Immunosuppression." In Pediatric Critical Care Medicine, 355–85. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6359-6_26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hassan, Fatemat A., and Tom J. Valikodath. "Cardiac Pharmacology." In Board Review Atlas of Pediatric Cardiology, 403–10. Cham: Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-59493-9_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pediatric pharmacology"

1

J., Camellia, Pramestutie H. R., and Hariadini A. L. ""Diarrhea Care Program" as Effective Pediatric Diarrhea Counseling Tool for Pharmacy Practice." In Annual International Conference on Pharmacology and Pharmaceutical Sciences. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2345-783x_pharma14.27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Leggas, Markos, Joseph Eckenrode, Yang Liu, Abhisek Mandal, Reiya Hayden, Oleg Tsodikov, Jon Thorson, and Jurgen Rorh. "Abstract A41: Novel mithramycin analogues with improved pharmacologic profile and efficacy in ETS transcription factor-driven tumors." In Abstracts: AACR Special Conference on the Advances in Pediatric Cancer Research; September 17-20, 2019; Montreal, QC, Canada. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.pedca19-a41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pediatric pharmacology"

1

Izmozherova, Nadezdha, Viktor Bakhtin, Marina Driker, Maria Dobrinskaya, Elena Safianik, and Muraz Shambatov. Electronic training course "Pharmacology for students of General Medicine and Pediatric faculties". SIB-Expertise, December 2022. http://dx.doi.org/10.12731/er0650.15122022.

Full text

Abstract:

Электронный учебный курс «Фармакология для студентов лечебно-профилактического и педиатрического факультетов» составлен в соответствии с требованиями следующих документов: Федеральный государственный образовательный стандарт высшего образования по специальности 31.05.01 Лечебное дело, утверждённый приказом Министерства науки и высшего образования Российской Федерации от 12.08.2020 г. № 988 Федеральный государственный образовательный стандарт высшего образования по специальности 31.05.02 Педиатрия, утвержденный приказом Министерства науки и высшего образования Российской Федерации от 12.08.2020 г. № 965 Профессиональный стандарт ""Врач-лечебник (врач-терапевт участковый)"" , утвержденный приказом Министерства труда и социальной защиты Российской Федерации от 21.03.2017 г. № 293н Профессиональный стандарт ""Врач-педиатр участковый"", утверждённый приказом Министерства труда и социальной защиты Российской Федерации от 27.03.2017 г. № 306н Цель изучения курса - овладение студентами необходимым объемом теоретических и практических знаний по фармакологии для освоения компетенций в соответствии с требованиями Федеральных государственных образовательных стандартов высшего образования. Задачи курса: Освоение общих принципов оформления рецептов и составления рецептурных прописей, умения выписывать в рецептах различные лекарственные формы Знание общих закономерностей фармакокинетики и фармакодинамики лекарственных средств. Умение анализировать действия лекарственных средств по совокупности их фармакологических эффектов, механизмов и локализации действия, фармакокинетики Умение оценивать возможности использования лекарственных средств для целей фармакотерапии на основе представлений об их свойствах Приобретение навыков выписывать лекарственные средства в рецептах при определенных патологических состояниях, исходя из особенностей фармакодинамики и фармакокинетики лекарственных препаратов Трудоемкость курса составляет 252 часа.

APA, Harvard, Vancouver, ISO, and other styles

2

Treadwell, Jonathan R., Mingche Wu, and Amy Y. Tsou. Management of Infantile Epilepsies. Agency for Healthcare Research and Quality (AHRQ), October 2022. http://dx.doi.org/10.23970/ahrqepccer252.

Full text

Abstract:

Objectives. Uncontrolled seizures in children 1 to 36 months old have serious short-term health risks and may be associated with substantial developmental, behavioral, and psychological impairments. We evaluated the effectiveness, comparative effectiveness, and harms of pharmacologic, dietary, surgical, neuromodulation, and gene therapy treatments for infantile epilepsies. Data sources. We searched Embase®, MEDLINE®, PubMed®, the Cochrane Library, and gray literature for studies published from January 1, 1999, to August 19, 2021. Review methods. Using standard Evidence-based Practice Center methods, we refined the scope and applied a priori inclusion criteria to the >10,000 articles identified. We ordered full text of any pediatric epilepsy articles to determine if they reported any data on those age 1 month to <36 months. We extracted key information from each included study, rated risk of bias, and rated the strength of evidence. We summarized the studies and outcomes narratively. Results. Forty-one studies (44 articles) met inclusion criteria. For pharmacotherapy, levetiracetam may cause seizure freedom in some patients (strength of evidence [SOE]: low), but data on other medications (topiramate, lamotrigine, phenytoin, vigabatrin, rufinamide, stiripentol) were insufficient to permit conclusions. Both ketogenic diet and the modified Atkins diet may reduce seizure frequency (SOE: low for both). In addition, the ketogenic diet may cause seizure freedom in some infants (SOE: low) and may be more likely than the modified Atkins diet to reduce seizure frequency (SOE: low). Both hemispherectomy/hemispherotomy and non-hemispheric surgical procedures may cause seizure freedom in some infants (SOE: low for both), but the precise proportion is too variable to estimate. For three medications (levetiracetam, topiramate, and lamotrigine), adverse effects may rarely be severe enough to warrant discontinuation (SOE: low). For topiramate, non-severe adverse effects include loss of appetite and upper respiratory tract infection (SOE: moderate). Harms of diets were sparsely reported. For surgical interventions, surgical mortality is rare for functional hemispherectomy/hemispherotomy and non-hemispheric procedures (SOE: low), but evidence was insufficient to permit quantitative estimates of mortality or morbidity risk. Hydrocephalus requiring shunt placement after multilobar, lobar, or focal resection is uncommon (SOE: low). No studies assessed neuromodulation or gene therapy. Conclusions. Levetiracetam, ketogenic diet, modified Atkins diet, and surgery all appear to be effective for some infants. However, the strength of the evidence is low for all of these modalities due to lack of control groups, low patient enrollment, and inconsistent reporting. Future studies should compare different pharmacologic treatments and compare pharmacotherapy with dietary therapy. Critical outcomes underrepresented in the literature include quality of life, sleep outcomes, and long-term development.

APA, Harvard, Vancouver, ISO, and other styles

3

Peterson, Bradley S., Joey Trampush, Margaret Maglione, Maria Bolshakova, Morah Brown, Mary Rozelle, Aneesa Motala, et al. ADHD Diagnosis and Treatment in Children and Adolescents. Agency for Healthcare Research and Quality (AHRQ), March 2024. http://dx.doi.org/10.23970/ahrqepccer267.

Full text

Abstract:

Objective. The systematic review assessed evidence on the diagnosis, treatment, and monitoring of attention deficit hyperactivity disorder (ADHD) in children and adolescents to inform a planned update of the American Academy of Pediatrics (AAP) guidelines. Data sources. We searched PubMed®, Embase®, PsycINFO®, ERIC, clinicaltrials.gov, and prior reviews for primary studies published since 1980. The report includes studies published to June 15, 2023. Review methods. The review followed a detailed protocol and was supported by a Technical Expert Panel. Citation screening was facilitated by machine learning; two independent reviewers screened full text citations for eligibility. We abstracted data using software designed for systematic reviews. Risk of bias assessments focused on key sources of bias for diagnostic and intervention studies. We conducted strength of evidence (SoE) and applicability assessments for key outcomes. The protocol for the review has been registered in PROSPERO (CRD42022312656). Results. Searches identified 23,139 citations, and 7,534 were obtained as full text. We included 550 studies reported in 1,097 publications (231 studies addressed diagnosis, 312 studies addressed treatment, and 10 studies addressed monitoring). Diagnostic studies reported on the diagnostic performance of numerous parental ratings, teacher rating scales, teen/child self-reports, clinician tools, neuropsychological tests, EEG approaches, imaging, and biomarkers. Multiple approaches showed promising diagnostic performance (e.g., using parental rating scales), although estimates of performance varied considerably across studies and the SoE was generally low. Few studies reported estimates for children under the age of 7. Treatment studies evaluated combined pharmacological and behavior approaches, medication approved by the Food and Drug Administration, other pharmacologic treatment, psychological/behavioral approaches, cognitive training, neurofeedback, neurostimulation, physical exercise, nutrition and supplements, integrative medicine, parent support, school interventions, and provider or model-of-care interventions. Medication treatment was associated with improved broadband scale scores and ADHD symptoms (high SoE) as well as function (moderate SoE), but also appetite suppression and adverse events (high SoE). Psychosocial interventions also showed improvement in ADHD symptoms based on moderate SoE. Few studies have evaluated combinations of pharmacological and youth-directed psychosocial interventions, and we did not find combinations that were systematically superior to monotherapy (low SoE). Published monitoring approaches for ADHD were limited and the SoE is insufficient. Conclusion. Many diagnostic tools are available to aid the diagnosis of ADHD, but few monitoring strategies have been studied. Medication therapies remain important treatment options, although with a risk of side effects, as the evidence base for psychosocial therapies strengthens and other nondrug treatment approaches emerge.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!